XIFAXAN® (rifaximin) For Adults with Overt HE and IBS-D XIFAXAN® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy recurrence and for the treatment of IBS-D in adults See Important Safety Information and full Prescribing Information on website
IBS-D Resources Support for You | XIFAXAN® (rifaximin) XIFAXAN ® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea in adults